American Diabetes Association

Stories

Landmark trial shows continuous glucose monitors cut A1c in type 2 diabetes patients not on insulin

Updated its Standards of Care in June 2026 to recommend CGM for adults with type 2 diabetes on any treatment regimen in which it helps manage the condition

For millions of Americans with type 2 diabetes who don't take insulin, checking blood sugar has meant fingerstick tests a few times a day. A 26-week trial published in the New England Journal of Medicine in October showed that continuous glucose monitors (CGMs), small sensors worn on the arm that stream glucose readings, kept patients in a healthy blood sugar range for about five extra hours each day.

Updated Oct 18

Scientists boycott American Diabetes Association over June conference ousters

Rule Changes

As of September 2026: Facing member boycott over handling of June ousters

American Diabetes Association (ADA) members are refusing to review grants and new article submissions for the group's flagship journal, Diabetes Care. The boycott is the latest escalation in a fight that began June 5, when security and New Orleans police removed five scientists from the ADA's annual meeting for distributing reprints of an editorial critical of federal cuts to diabetes research.

Updated Sep 11